awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47095186-12157C08-0ECC-45FF-9A97-6AC22457E116
Q47095186-12157C08-0ECC-45FF-9A97-6AC22457E116
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47095186-12157C08-0ECC-45FF-9A97-6AC22457E116
SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial.
P2860
Q47095186-12157C08-0ECC-45FF-9A97-6AC22457E116
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47095186-12157C08-0ECC-45FF-9A97-6AC22457E116
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64dbcecd43b79d56c198b87700c2ec25a5d441ef
P2860
Dapagliflozin treatment for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.